Iglesias Manuela, Martinez Elisabeth, Badia Joan Ramon, Macchiarini Paolo
Department of General Thoracic Surgery, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
Ann Thorac Surg. 2008 Jan;85(1):237-44; discussion 244. doi: 10.1016/j.athoracsur.2007.06.004.
The purpose of this study was to evaluate the feasibility of integrating an artificial, pumpless extracorporeal membrane ventilator (Novalung) to near static mechanical ventilation and its efficacy in patients with severe postresectional acute respiratory distress syndrome (ARDS) unresponsive to optimal conventional treatment.
Indications were severe postresectional and unresponsive acute respiratory distress syndrome, hemodynamic stability, and no significant peripheral arterial occlusive disease or heparin-induced thrombocytopenia. Management included placement of the arteriovenous femoral transcutaneous interventional lung-assist membrane ventilator, lung rest at minimal mechanical ventilator settings, and optimization of systemic oxygen consumption and delivery.
Among 239 pulmonary resections performed between 2005 and 2006, 7 patients (2.9%) experienced, 4 +/- 0.8 days after 5 pneumonectomies and 2 lobectomies, a severe (Murray score, 2.9 +/- 0.3) acute respiratory distress syndrome unresponsive to 4 +/- 2 days of conventional therapy. The interventional lung-assist membrane ventilator was left in place 4.3 +/- 2.5 days, and replaced only once for massive clotting. During this time, 29% +/- 0.3% or 1.4 +/- 0.36 L/min of the cardiac output perfused the device, without hemodynamic impairment. Using a sweep gas flow of 10.7 +/- 3.8 L/min, the device allowed an extracorporeal carbon dioxide removal of 255 +/- 31 mL/min, lung(s) rest (tidal volume, 2.7 +/- 0.8 mL/kg; respiratory rate, 6 +/- 2 beats/min; fraction of inspired oxygen, 0.5 +/- 0.1), early (<24 hours) significant improvement of respiratory function, and reduction of plasmatic interleukin-6 levels (p < 0.001) and Murray score (1.25 +/- 0.1; p < 0.003). All but 1 patient (14%) who died of multiorgan failure were weaned from mechanical ventilation 8 +/- 3 days after removal of the interventional lung-assist membrane ventilator, and all of them were discharged from the hospital.
The integration of this device to near static mechanical ventilation of the residual native lung(s) is feasible and highly effective in patients with severe and unresponsive acute respiratory distress syndrome after pulmonary resection.
本研究的目的是评估将人工无泵体外膜肺通气装置(Novalung)与近静态机械通气相结合的可行性,以及其在严重的肺切除术后急性呼吸窘迫综合征(ARDS)患者中的疗效,这些患者对最佳常规治疗无反应。
入选标准为严重的肺切除术后且对急性呼吸窘迫综合征治疗无反应、血流动力学稳定、无明显外周动脉闭塞性疾病或肝素诱导的血小板减少症。治疗措施包括放置股动静脉经皮介入肺辅助膜肺通气装置、在最低机械通气设置下让肺休息以及优化全身氧消耗和输送。
在2005年至2006年期间进行的239例肺切除术中,7例患者(2.9%)在5例全肺切除和2例肺叶切除术后4±0.8天出现严重(Murray评分2.9±0.3)急性呼吸窘迫综合征,对4±2天的常规治疗无反应。介入肺辅助膜肺通气装置留置4.3±2.5天,仅因大量凝血更换过一次。在此期间,心输出量的29%±0.3%或1.4±0.36L/min灌注该装置,未出现血流动力学损害。使用10.7±3.8L/min的扫气流量,该装置可实现255±31mL/min的体外二氧化碳清除,肺休息(潮气量2.7±0.8mL/kg;呼吸频率6±2次/分钟;吸入氧分数0.5±0.1),呼吸功能早期(<24小时)显著改善,血浆白细胞介素-6水平降低(p<0.001),Murray评分降低(1.25±0.1;p<0.003)。除1例死于多器官功能衰竭的患者(14%)外,其余患者在移除介入肺辅助膜肺通气装置后8±3天脱机,所有患者均出院。
对于肺切除术后严重且对急性呼吸窘迫综合征治疗无反应的患者,将该装置与剩余肺的近静态机械通气相结合是可行且高效的。